Opioids: Boston trial opens what could be the year of reckoning for executives
Drug company executives appearing in court in Boston this week have been accused of running “a criminal enterprise” and putting greed before patient safety as they pushed prescription narcotics during the opioids crisis, blighting the health of America.
The defendants are the first painkiller manufacturing bosses to stand trial over conduct authorities say contributed to an overdose epidemic that has killed hundreds of thousands of people in the past 20 years, regardless of region, age, race and income.
If the Boston trial and others scheduled to get underway later this year are anything to go by, 2019 is now shaping up as the start of a reckoning for the pharmaceutical giants still making billions from opioids.
Assistant US attorney David Lazarus told jurors in the federal court in Boston that John Kapoor and the company he created, Insys Therapeutics, ran a nationwide kickback and conspiracy scheme that effectively bribed doctors to routinely prescribe patients an addictive fentanyl spray that was much powerful than morphine and had been approved to alleviate the pain of advanced cancer.
TriMark Legal Funding provides non-recourse pre settlement lawsuit funding and post settlement loans to injured plaintiffs nationwide. Call (877) 932-2628 with questions or to apply for funding.
This post originally appeared here: https://www.theguardian.com/us-news/2019/jan/31/john-kapoor-insys-trial-opioids-crisis
Click here to see the full original article.